NCT03439800

Brief Summary

INTRODUCTION: Mental practice (MP) and action observation (AO) are characterized as cognitive strategies that contribute to motor planning and learning in diverse populations. Individuals with Parkinson's Disease (PD) are recent targets, since, with disease progression, they need external strategies to aid in motor organization. However, there is still no evidence of the efficacy of MP and AO in the gait of PD. OBJECTIVES: To compare the effects of physical practice preceded by MP and AO on gait performance in individuals with Idiopathic PD (IPD). METHODS: A controlled, randomized, single-blind clinical trial with 66 individuals with IPD, aged between 50 and 75 years, without cognitive deficit and in the moderate phase of the disease will be performed. For the inclusion and characterization of the sample, the following instruments / equipment will be used: (1) Identification form (sociodemographic, clinical and anthropometric aspects); (2) Mini Mental State Examination and Montreal Cognitive Assessment (cognitive level); (3) Hoehn and Yahr Scale (level of physical disability); (4) Revised Movement Imagery Questionnaire (sharpness of the mental image); (5) Qualisys Motion Capture Systems® (gait kinematics); (6) Emotiv Epoc + (electroencephalographic activity); (7) Unified Parkinson's Disease Rating Scale - UPDRS (motor function and activities of daily living); (8) Timed Up and Go Test - TUG Test (mobility); and (9) Parkinson's Disease Questionnaire - PDQ-39 (quality of life).Participants included will be randomly assigned to two groups: experimental (n = 33), who will participate in MP + AO and physical gait practice; and control group (n = 33), who will participate only in the physical practice of gait. Both groups will be submitted to 12 training sessions (3x / week, for 4 weeks) and will be reevaluated 10 minutes, 7 days and 30 days after the last training session with respect to items (4), (5), (6) and (8) of the evaluation. Primary outcomes will be velocity, stride length and range of motion of the hip and the secondary ones will be sharpness of the mental image, electroencephalographic activity and performance in the TUG Test. The normality in the data distribution will be verified through the Shapiro-Wilk test. The "t" test and the Mann-Whitney test will be used to verify the homogeneity of the groups in the baseline. A repeated measures ANOVA will verify the interaction between the groups at the moments observed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

February 15, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 20, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

February 6, 2019

Status Verified

February 1, 2019

Enrollment Period

1.5 years

First QC Date

November 15, 2017

Last Update Submit

February 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Velocity

    Gait velocity in meters/second evaluated with Qualisys Motion Capture System

    Change from Baseline Velocity at 1 day, 7 days and 30 days after training sessions

Secondary Outcomes (3)

  • Electroencephalographic activity

    Change from Baseline Electroencephalographic activity at 1 day, 7 days and 30 days after training sessions

  • Mobility

    Change from Baseline Mobility at 1 day, 7 days and 30 days after training sessions

  • Stride length

    change from Baseline Stride length at 1 day, 7 days and 30 days after training sessions

Study Arms (2)

Mental and Physical Practice

EXPERIMENTAL

Action observation: is defined as the observation of the motor action, in this study, through a video. Mental Practice: is defined as motor imagery training with the aim of improving the engine performance. Is the imagination of a motor action without its physical implementation. Physical Practice: is the execution of the motor action.

Other: Mental and Physical Practice

Physical Practice

ACTIVE COMPARATOR

Physical Practice: is the execution of the motor action.

Other: Physical Practice

Interventions

1. Subjects will see a video of the typical gait and will attempt to analyze the sequence of the gait cycle. 2. They will imagine themselves walking in the first-person perspective (kinesthetic) using the gait of the non-pathological pattern during 2 minutes. 3. From the 1st to 4th session, the subjects will perform gait with corrections identified in previously in the video for 2 minutes. 4. From 5th to 8th session: the subjects will do the protocol already described, however, the imagined gait will be in an environment with obstacles, also for 2 minutes. They will continue with the physical practice of the gait with obstacles. 5. From 9th to final training session: both mental and physical practice of the dual task gait.

Mental and Physical Practice

1. Subjects will see a video about PD which does not mention physiotherapy treatments related to gait and they will explain their understanding about the theme. 2. Then, the patients will make the physical gait protocol. Patients will be invited to perform the gait, in flat and firm ground with a length of 60 meters. The execution will be carried out for 10 minutes. 3. From the 5th to 8th session, the subjects will do the physical practice of the gait with obstacles (which will be: going through 2 cones zigzag, going up and down 1 step, going through a narrow door, going up and down 1 ramp, going over 1 box of shoes, climbing a ramp, going down 1 step) for 2 minutes. 4. From the 9th to the final training session, the subjects will do physical practice of the dual task gait.

Physical Practice

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of PD according to the report of a neurologist;
  • Age between 50 and 75 years;
  • In the moderate stage of the disease (between stages 2 and 3 of the Hoehn and Yahr Scale);
  • Use of antiparkinsonian medication;
  • Do not present cognitive deficits, according to the Mini Mental State Examination - MMSE. The cutoff point will be defined considering the individual's schooling (Illiterates: 18; With school instruction: 24);
  • Ability to imagine motor acts in kinesthetic mode (according to the Revised Movement Imagery Questionnaire - MIQ-R). The cut-off point will be 20 for the kinesthetic modality, indicating that it is at least "a little easy to feel" the kinesthetically imagined movement;
  • Have not undergone stereotaxic surgery.

You may not qualify if:

  • Individuals with other associated neurological diseases;
  • Individuals with musculoskeletal disorders, not related to the disease, but that impair gait;
  • Individuals with hemodynamic instability before or during training;
  • Individuals with uncorrected visual or auditory changes;
  • Individuals who do not understand some stage of the training protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lorenna Santiago

Parnamirim, Rio Grande Do Norte, 59148-520, Brazil

RECRUITING

Related Publications (1)

  • Nascimento IAPDS, Santiago LMM, de Souza AA, Pegado CL, Ribeiro TS, Lindquist ARR. Effects of motor imagery training of Parkinson's disease: a protocol for a randomized clinical trial. Trials. 2019 Nov 9;20(1):626. doi: 10.1186/s13063-019-3694-8.

MeSH Terms

Conditions

Parkinson DiseaseGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

November 15, 2017

First Posted

February 20, 2018

Study Start

February 15, 2018

Primary Completion

August 1, 2019

Study Completion

December 1, 2019

Last Updated

February 6, 2019

Record last verified: 2019-02

Locations